PATENT CLAIM ANALYSIS

Application Number: 16175915
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["546", "064000"]

Abstract:
The invention described herein pertains to selective Janus kinase (JAK) inhibitors and methods of use thereof. Also described are methods for treating diseases involved abnormal JAK/STAT signaling pathway in mammals using the described selective JAK inhibitors or a pharmaceutical formulation thereof.

Claim (Index 4):
The compound according to  claim 3 , wherein R 1  is an optionally substituted C3-C8 cycloalkyl.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 97.0
- Lexical Diversity: 1.21622
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15973569', '15144311', '14111157', '14110391', '14119673']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7874936818898042
- 35 USC 102 Novelty (BERT): 0.5569266892791779
- Combined Prediction Score: 0.7644369826287416
- Mean Citation Score: 361.95723
- Max Citation Score: 446.05054
- Similarity Product: 295.77837481384165

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test